Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
Daiichi Sankyo appointed John Tsai, MD as Global Head of R&D, succeeding Ken Takeshita, MD; the leadership change could influence R&D strategy and external collaborations.
Why it mattersDaiichi Sankyo naming John Tsai as Global Head of R&D may shift oncology pipeline priorities, affecting partner deals.